Biotech Archives - Page 659 of 733

1 minute read

Seelos Therapeutics Announces Participation Of Acadia Healthcare In The Registration Directed Study Of SLS-002 (Intranasal Racemic Ketamine) For Acute Suicidal Ideation And Behavior In Patients With Major Depressive Disorder

September 13, 8:08 AM

NEW YORK, Sept. 13, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (NASDAQ:SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases,

ACHC

1 minute read

Pardes Biosciences Announces Commencement Of Phase 2 Trial Evaluating PBI-0451 For The Treatment Of SARS-CoV-2 Infections

By Benzinga Newsdesk

September 13, 8:04 AM

Phase 2 trial expected to enroll 210 patients at approximately 75 sites to evaluate antiviral activity, safety, and efficacy of PBI-0451 versus placebo Interim data from Phase 2 anticipated in Q1 2023

PRDS

2 minute read

aTyr Pharma Receives FDA Fast Track Designation For Efzofitimod For Treatment Of Systemic Sclerosis-Associated Interstitial Lung Disease

By Benzinga Newsdesk

September 13, 8:01 AM

aTyr Pharma, Inc. (NASDAQ:LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the U.S.

LIFE

5 minute read

FDA Schedules AdComm Review For First Over The Counter Birth Control Pill

By Vandana Singh

September 13, 6:40 AM

The FDA has set a date to review what could become the first over-the-counter birth control pill approved in the…

PRGO

1 minute read

At R&D Day, Alpine Immune Highlights Updates On Autoimmune, Immuno-Oncology Programs

By Vandana Singh

September 13, 6:15 AM

Alpine Immune Sciences Inc (NASDAQ:ALPN) announced clinical updates from ALPN-303 and davoceticept programs. Key highlights from the announcement include: ALPN-303 Well…

ALPN

4 minute read

Important Biotech Catalysts For September 12, 2022 – End Of The Day Summary

By Ragothaman Srinivasan

September 12, 6:29 PM

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Mersana Therapeutics’ (NASDAQ:MRSN) lead candidate…

ACAD

1 minute read

FDA Grants Syros Pharmaceuticals Orphan Drug Designation For Treatment Of Pancreatic Cancer – FDA

By Benzinga Newsdesk

September 12, 5:51 PM

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=898122

SYRS

2 minute read

Adamis Achieves Enrolment Target In Mid-Stage Covid-19 Study, Awaits Data Safety Monitoring Board Review Later This Month

By Ragothaman Srinivasan

September 12, 4:49 PM

Adamis Pharmaceuticals (NASDAQ: ADMP) announced that it has reached the initial planned enrollment target in the ongoing U.S. Phase 2/3 clinical trial investigating Tempol as a treatment for COVID-19.

ADMP

2 minute read

Cardiff Oncology Announces Plans For A Randomized Trial, Durability Of Responses In Ongoing Phase 1b/2 Trial In Metastatic Colorectal Cancer And Additional Business Updates

By Benzinga Newsdesk

September 12, 4:11 PM

Next trial in RAS-mutated mCRC (ONSEMBLE) is a randomized Phase 2 trial to demonstrate onvansertib's contribution to SoC and position for a possible accelerated approval opportunity; topline data expected in 2H

CRDF